Literature DB >> 9107353

Pathophysiological mechanisms in immune inner ear disease.

J L Dornhoffer1, J G Arenberg, I K Arenberg, G E Shambaugh.   

Abstract

Immune inner ear disease is a somewhat controversial entity which describes cochleovestibular dysfunction that is related to immune-mediated mechanisms. The diagnosis of this disease is based on clinical presentation and response to various treatment protocols. Unfortunately, the presentation is variable and the treatment empirical, and this has caused much confusion in the diagnosis and management of the condition. To elucidate the variable nature of the disease, it is important to understand that more than one mechanism of immune injury may be involved. This paper attempts to classify clinical and experimental cases of immune inner ear disease with regard to the Gell and Coombs classification scheme of immune-mediated injury. By understanding the different pathophysiological mechanisms involved, the clinician should be better able to diagnose and manage this difficult problem in a directed fashion. The ramifications of the proposed classification system on the diagnosis, treatment and future research of immune inner ear disease are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9107353     DOI: 10.3109/00016489709124018

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  9 in total

1.  Cogan's syndrome: an oculo-audiovestibular disease.

Authors:  J R García Berrocal; J A Vargas; M Vaquero; S Ramón y Cajal; R A Ramírez-Camacho
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

2.  Incidence of Hypothyroidism in Meniere's Disease.

Authors:  U P Santosh; M S Sudhakar Rao
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  Cogan's syndrome: achievement of complete resolution of auditory deficit with steroids.

Authors:  Pritam Singh; Monica Gupta; S S Lehl; Kamal Singh
Journal:  BMJ Case Rep       Date:  2013-05-22

4.  Vascular Pathophysiology in Hearing Disorders.

Authors:  Dennis R Trune; Anh Nguyen-Huynh
Journal:  Semin Hear       Date:  2012-08

5.  Low dose combination steroids control autoimmune mouse hearing loss.

Authors:  Dennis R Trune; J Beth Kempton
Journal:  J Neuroimmunol       Date:  2010-08-30       Impact factor: 3.478

Review 6.  Corticosteroid therapy for hearing and balance disorders.

Authors:  Dennis R Trune; Barbara Canlon
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

7.  Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.

Authors:  Dennis R Trune; J Beth Kempton
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

8.  The role of allergy in the etiopathogenesis of idiopathic sudden sensorineural hearing loss.

Authors:  Erol Keleş; Emrah Sapmaz; Ahmet Gödekmerdan
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-25       Impact factor: 2.503

9.  Hearing evaluation with ABR in pediatric patients with celiac disease.

Authors:  Neslihan Yaprak; Ersin Sayar; Alper Tunga Derin; Aslı Bostancı; Murat Turhan; Aygen Yılmaz
Journal:  Turk J Gastroenterol       Date:  2020-02       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.